Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma

被引：30
|
作者：
Zanjani, Leili Saeednejad [1 ]
Madjd, Zahra [1 ,2 ]
Abolhasani, Maryam [1 ,3 ]
Rasti, Arezoo [1 ]
Fodstad, Oystein [4 ,5 ]
Andersson, Yvonne [4 ]
Asgari, Mojgan [1 ,3 ]
机构：
[1] Iran Univ Med Sci, Oncopathol Res Ctr, Tehran, Iran
[2] Iran Univ Med Sci, Fac Adv Technol Med, Dept Mol Med, Tehran, Iran
[3] Iran Univ Med Sci, Hasheminejad Kidney Ctr, Tehran, Iran
[4] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumor Biol, N-0424 Oslo, Norway
[5] Univ Oslo, Fac Med, Inst Clin Med, N-0310 Oslo, Norway
来源：
BIOMARKERS IN MEDICINE | 2018年 / 12卷 / 01期
关键词：
cancer stem cells; CD44; renal cell carcinoma; tissue microarray; CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; MICROSCOPIC VENOUS INVASION; INTERNATIONAL-SOCIETY; PROGNOSTIC VALUE; METASTASIS; MOLECULE; IDENTIFICATION; POPULATIONS; ACQUISITION;
D O I：
10.2217/bmm-2017-0142
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Aim: Although CD44 has been suggested as a prognostic marker in renal cell carcinoma (RCC), the prognostic significance of this marker in three main subtypes of RCC is still unclear. Thus, the present study was conducted to evaluate the expression and prognostic significance of CD44 as a cancer stem cell marker in different histological subtypes of RCC. Methodology & results: CD44 expression was evaluated in 206 well-defined renal tumor samples using immunohistochemistry on tissue microarrays. Higher CD44 expression was associated with more aggressive behavior, tumor progression and worse prognosis in clear cell RCC (ccRCC) but not in papillary and chromophobe RCC subtypes. Discussion & conclusion: Cancer stem cell marker CD44 may be a promising target for cancer treatment only in ccRCC.
引用
收藏
页码：45 / 61
页数：17
相关论文
共 50 条
  • [1] Infiltration of tumor-associated macrophages is involved in CD44 expression in clear cell renal cell carcinoma
    Ma, Chaoya
    Komohara, Yoshihiro
    Ohnishi, Koji
    Shimoji, Tetsu
    Kuwahara, Nao
    Sakumura, Yasuo
    Matsuishi, Kozue
    Fujiwara, Yukio
    Motoshima, Takanobu
    Takahashi, Wataru
    Yamada, Sohsuke
    Kitada, Shohei
    Fujimoto, Naohiro
    Nakayama, Toshiyuki
    Eto, Masatoshi
    Takeya, Motohiro
    CANCER SCIENCE, 2016, 107 (05): : 700 - 707
  • [2] Cytoplasmic expression of CD133 sternness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma
    Zanjani, Leili Saeednejad
    Madjd, Zahra
    Abolhasani, Maryam
    Andersson, Yvonne
    Rasti, Arezoo
    Shariftabrizi, Ahmad
    Asgari, Mojgan
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2017, 103 (02) : 218 - 228
  • [3] Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma
    Wang, Huimin
    Tan, Mingzi
    Zhang, Song
    Li, Xiao
    Gao, Jian
    Zhang, Danye
    Hao, Yingying
    Gao, Song
    Liu, Juanjuan
    Lin, Bei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (02) : 3391 - 3404
  • [4] CD44 Is Associated with the Aggressive Phenotype of Nasopharyngeal Carcinoma through Redox Regulation
    Lin, Chien-Hung
    Hung, Peir-Haur
    Chen, Yann-Jang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (07) : 13266 - 13281
  • [5] Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors
    Boxberg, Melanie
    Goetz, Carolin
    Haidari, Selgai
    Dorfner, Christiane
    Jesinghaus, Moritz
    Drecoll, Enken
    Boskov, Marko
    Wolff, Klaus D.
    Weichert, Wilko
    Haller, Bernhard
    Kolk, Andreas
    HISTOPATHOLOGY, 2018, 73 (04) : 559 - 572
  • [6] CD44 as a stem cell marker in head and neck squamous cell carcinoma
    Faber, Anne
    Barth, Christine
    Hoermann, Karl
    Kassner, Stefan
    Schultz, Johannes David
    Sommer, Ulrich
    Stern-Straeter, Jens
    Thorn, Carsten
    Goessler, Ulrich Reinhart
    ONCOLOGY REPORTS, 2011, 26 (02) : 321 - 326
  • [7] CD44 Is a Prognostic Biomarker Correlated With Immune Infiltrates and Metastasis in Clear Cell Renal Cell Carcinoma
    Ma, Junjie
    Wu, Ruoyu
    Chen, Zhiguo
    Zhang, Yuqing
    Zhai, Wei
    Zhu, Rujian
    Zheng, Junhua
    ANTICANCER RESEARCH, 2023, 43 (08) : 3493 - 3506
  • [8] CD44 Expression in Clear Cell Renal Cell Carcinoma (ccRCC) Correlates with Tumor Grade and Patient Survival and Is Affected by Gene Methylation
    Papanastasiou, Anastasios D.
    Peroukidis, Stavros
    Sirinian, Chaido
    Arkoumani, Elisavet
    Chaniotis, Dimitrios
    Zizi-Sermpetzoglou, Adamantia
    GENES, 2024, 15 (05)
  • [9] Expression of the PTTG1 Oncogene Is Associated with Aggressive Clear Cell Renal Cell Carcinoma
    Wondergem, Bill
    Zhang, Zhongfa
    Huang, Dachuan
    Ong, Choon Kiat
    Koeman, Julie
    Van't Hof, David
    Petillo, David
    Ooi, Aikseng
    Anema, John
    Lane, Brian
    Kahnoski, Richard J.
    Furge, Kyle A.
    Teh, Bin Tean
    CANCER RESEARCH, 2012, 72 (17) : 4361 - 4371
  • [10] Prognostic Significance of CD24 in Clear Cell Renal Cell Carcinoma
    Arik, Deniz
    Can, Cavit
    Dundar, Emine
    Kabukcuoglu, Sare
    Pasaoglu, Ozgul
    PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (02) : 409 - 416
12345